Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.

by Tetsuro Takayama, Hirotoshi Ebinuma, Shinichiro Tada, Yoshiyuki Yamagishi, Kanji Wakabayashi, Keisuke Ojiro, Takanori Kanai, Hidetsugu Saito, Toshifumi Hibi, Keio Association for the Study of Liver Diseases
Published 2011-01-01